Translational Neuroscience 2 (TN2)
Description: Three years ago we established an innovative and successful 4-year Translational Neuroscience PhD Programme (‘TN1’) designed to address the fundamental problems in translating advances in discovery neuroscience to the clinic. We are equipping cohorts of outstanding students with the means to resolve these problems by providing rigorous, cross-disciplinary, cutting-edge training in the neuroscience of brain disorders across the lifespan. Demand has proved enormous. In TN2, we shall continue the key aim of TN1 by leveraging the opportunities offered by the highly collaborative Edinburgh Neuroscience community of world-leading clinical and fundamental scientists. This community has been substantially enhanced by recent key strategic developments that massively expand our portfolio of neuroscience research, including new opportunities in data science driven by a £250M CityDeal and new translational expertise introduced by our £23M Dementia Research Institute, our $20M Simons Initiative for the Developing Brain and our £50M Institute for Regeneration and Repair. By also incorporating lessons learnt from our TN1 cohorts and from relevant stakeholders to enhance student welfare, diversity and career options, our programme will provide exceptional training in translational neuroscience, key skills for research and other careers worldwide, and be a beacon of best practise in student development.
Funder: Wellcome Trust
Amount: £5,509,000
Funding type: training-grant
Funder scheme: Cellular and Molecular Neuroscience
Start date: 2020-09-14
End date: 2028-09-13
Investigators: Stephen Lawrie, David Price, Peter Kind, Anna Williams, Tara Spires-Jones, Sue Fletcher-Watson
Institution: University of Edinburgh
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 28
Funder award ID: 218493
OpenAlex ID: G546761635